Frost & Sullivan releases the 'Nucleic Acid Drug Market Industry Status quo and Future Development Report'

Nucleic acid drugs are one of the most clinically promising frontier areas in future biopharmaceuticals. On May 20, 2022, Frost & Sullivan (hereinafter referred to as 'Frost & Sullivan') officially released the 'Nucleic Acid Drug Market Industry Status and Future Development Research Report' (hereinafter referred to as 'the Report'), which sorts out the development history of the nucleic acid drug industry, focuses on key R&D technologies for nucleic acid drugs, and provides insights into the future development trends of the industry, serving as a reference for those interested in the field of nucleic acid drugs.